Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1978381 | 0.89 | FTO (0.52) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL7646663 | 0.89 | FTO (0.52) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL11310755 | 0.89 | FTO (0.52) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL1254421 | 0.88 | FTO (0.64) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL5149281 | 0.88 | FTO (0.55) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL9428188 | 0.86 | FTO (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL9350491 | 0.86 | FTO (0.47) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL9427469 | 0.85 | HPGD (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL15778575 | 0.84 | FTO (0.47) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL905219 | 0.84 | FTO (0.47) | FTOMAPTHPGDMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1022 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007122602-A1 | A METHOD AND SYSTEM FOR MEASURING MEMBRANE POTENTIAL BASED ON FLUORESCENCE POLARIZATION | SENG ENTERPRISES LTD. (CY) | 2007-11-01 | — | — | WO | claimed |
| US-20070254276-A1 | Method and system for measuring membrane potential based on fluorescence polarization | SENG ENTERPRISES LTD. (CY) | 2007-11-01 | — | — | US | claimed |
| US-6794158-B2 | FLUORESCENT PROBE FOR USE AS DIAGNOSTIC TOOL IN MONITORING PREFERENTIAL ENZYME ACTIVITY | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-09-21 | — | — | US | claimed |
| US-20030082665-A1 | Fluorescence polarization assay | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2003-05-01 | — | — | US | claimed |
| WO-2002082082-A2 | FLUORESCENCE POLARIZATION ASSAY | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2002-10-17 | — | — | WO | claimed |
| EP-0702689-A4 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR 3-PHENYL-1-ADAMANTANEACETIC ACIDS | ABBOTT LAB (US) | 1997-10-22 | — | — | EP | claimed |
| EP-0708767-A4 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR CARBAZOLE AND DIBENZOFURAN DERIVATIVES | ABBOTT LAB (US) | 1996-10-02 | — | — | EP | claimed |
| EP-0708767-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR CARBAZOLE AND DIBENZOFURAN DERIVATIVES | ABBOTT LABORATORIES (US) | 1996-05-01 | — | — | EP | claimed |
| EP-0702689-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR 3-PHENYL-1-ADAMANTANEACETIC ACIDS | ABBOTT LABORATORIES (US) | 1996-03-27 | — | — | EP | claimed |
| US-5424414-A | Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids | ABBOTT LABORATORIES (US) | 1995-06-13 | — | — | US | claimed |
| WO-1995003296-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR CARBAZOLE AND DIBENZOFURAN DERIVATIVES | ABBOTT LABORATORIES (US) | 1995-02-02 | — | — | WO | claimed |
| WO-1994029329-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR 3-PHENYL-1-ADAMANTANEACETIC ACIDS | ABBOTT LABORATORIES (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1993020074-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR ACRIDINE-9-CARBOXYLIC ACIDS | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | claimed |
| WO-1993020094-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR QUINOLINE | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | claimed |
| US-5145790-A | Immunoassay, fluorescein derivative | ABBOTT LABORATORIES (US) | 1992-09-08 | — | — | US | claimed |
| EP-0455058-A2 | Reagents and method for detecting polychlorinated biphenyls | ABBOTT LABORATORIES (US) | 1991-11-06 | — | — | EP | claimed |
| US-20260140105-A1 | METHODS AND SYSTEMS FOR ANALYTE DETECTION AND ANALYSIS | ULTIMA GENOMICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260132459-A1 | COMPOSITIONS AND METHODS FOR PREPARING NUCLEIC ACID NANOSTRUCTURES USING COMPACTION OLIGONUCLEOTIDES | ELEMENT BIOSCIENCES INC (US) | 2026-05-14 | — | — | US | disclosed |
| EP-0199042-A1 | Procainamide assay, tracers, immunogens and antibodies | ABBOTT LABORATORIES (US) | 1986-10-29 | — | — | EP | disclosed |
| EP-0194352-A2 | Salicylate assay, tracers, immunogens and antibodies | ABBOTT LABORATORIES (US) | 1986-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260140105-A1 | METHODS AND SYSTEMS FOR ANALYTE DETECTION AND ANALYSIS | SRMS, CFD, STUB1 | FTO 1073/4885MAPT 915/4885HPGD 4225/4885 |
| US-20260132459-A1 | COMPOSITIONS AND METHODS FOR PREPARING NUCLEIC ACID NANOSTRUCTURES USING COMPACTION OLIGONUCLEOTIDES | PCNA, POLM, RNGTT | FTO 2315/4885MAPT 4008/4885HPGD 4842/4885 |
| US-20030082665-A1 | Fluorescence polarization assay | EPHX1, EPHX2, LTA4H | FTO 539/4885MAPT 4854/4885HPGD 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.